Laboratoire d'Hématologie et Institut Cardiovasculaire Nancy, Centre Hospitalier Universitaire, Nancy, France.
Inserm U961, Nancy Université, Nancy, France.
Thromb J. 2012 Aug 21;10(1):15. doi: 10.1186/1477-9560-10-15.
Bleeding remains a potentially lethal complication of cardio-pulmonary bypass (CPB) surgery. The purpose of this study was to obtain a better insight into in vitro thrombin generation in the context of CPB.
We used Calibrated Automated Thrombography to assess blood coagulation of 10 low-risk patients operated for valve replacement with CPB, under 2 experimental conditions, one implicating platelets as platelet dysfunction has been described to occur during CPB.
Our main finding was that CPB-induced coagulopathy was differently appreciated depending on the presence or absence of platelets: the decrease in thrombin generation was much less pronounced in their presence (mean endogenous thrombin potential change values before and after CPB were -3.9% in the presence of platelets and -39.6% in their absence).
Our results show that experimental conditions have a profound effect in the study of in vitro thrombin generation in the context of CPB.
出血仍然是体外心肺循环(CPB)手术潜在的致命并发症。本研究的目的是更好地了解 CPB 背景下体外凝血酶生成的情况。
我们使用校准自动血栓形成法评估了 10 名低危瓣膜置换术患者 CPB 下的血液凝固情况,在两种实验条件下,一种是血小板功能障碍,因为已有研究描述了 CPB 期间会发生血小板功能障碍。
我们的主要发现是,CPB 引起的凝血功能障碍的评估因血小板的存在与否而不同:在血小板存在的情况下,凝血酶生成的减少不那么明显(CPB 前后内源性凝血酶潜能变化值在血小板存在时为-3.9%,在血小板不存在时为-39.6%)。
我们的结果表明,实验条件对 CPB 背景下体外凝血酶生成的研究有深远的影响。